Yang Ou

497 total citations · 1 hit paper
25 papers, 277 citations indexed

About

Yang Ou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Yang Ou has authored 25 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yang Ou's work include Cardiovascular Function and Risk Factors (6 papers), CRISPR and Genetic Engineering (3 papers) and Acute Myeloid Leukemia Research (3 papers). Yang Ou is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), CRISPR and Genetic Engineering (3 papers) and Acute Myeloid Leukemia Research (3 papers). Yang Ou collaborates with scholars based in China, United States and United Kingdom. Yang Ou's co-authors include Yu Wu, Milton Packer, Barry A. Borlaug, Christopher M. Kramer, Karla Hurt, Venu Menon, Joseph M DiMaria, Dustin Ruff, Masahiro Murakami and Liping Yang and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Yang Ou

24 papers receiving 276 citations

Hit Papers

Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissu... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
    2024 63 citations Christopher M. Kramer, Barry A. Borlaug et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Ou China 9 89 69 59 57 53 25 277
Kira Kuschnerus Germany 7 84 0.9× 61 0.9× 32 0.5× 24 0.4× 48 0.9× 12 235
Yasuhiko Nakao Japan 8 88 1.0× 25 0.4× 37 0.6× 27 0.5× 35 0.7× 31 262
Cristina Fhied United States 11 123 1.4× 22 0.3× 38 0.6× 111 1.9× 83 1.6× 27 318
L van Toorn Netherlands 5 91 1.0× 35 0.5× 29 0.5× 20 0.4× 30 0.6× 7 328
Fong To Sweden 10 69 0.8× 63 0.9× 17 0.3× 31 0.5× 25 0.5× 13 320
Maiko Hajime Japan 11 89 1.0× 32 0.5× 99 1.7× 10 0.2× 40 0.8× 20 388
Joshua Balog United States 4 39 0.4× 77 1.1× 30 0.5× 218 3.8× 130 2.5× 7 346
Emina Vorkapić Sweden 12 90 1.0× 92 1.3× 17 0.3× 151 2.6× 29 0.5× 18 357
Chun Huang China 11 94 1.1× 65 0.9× 60 1.0× 24 0.4× 32 0.6× 19 257

Countries citing papers authored by Yang Ou

Since Specialization
Citations

This map shows the geographic impact of Yang Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ou more than expected).

Fields of papers citing papers by Yang Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ou. The network helps show where Yang Ou may publish in the future.

Co-authorship network of co-authors of Yang Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Ou. A scholar is included among the top collaborators of Yang Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Ou. Yang Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Appelboam, Andrew, Obioha C. Ukoumunne, Sarah Black, et al.. (2025). Evaluation of Out-of-Hospital Use of a Valsalva Assist Device in the Emergency Treatment of Supraventricular Tachycardia. Annals of Emergency Medicine. 86(6). 659–673.
2.
Peng, Junjie, Jiannong Cao, Yang Ou, et al.. (2025). Effectiveness of virtual reality technology in rehabilitation after anterior cruciate ligament reconstruction: A systematic review and meta-analysis. PLoS ONE. 20(3). e0314766–e0314766. 3 indexed citations
3.
Borlaug, Barry A., Michael R. Zile, Christopher M. Kramer, et al.. (2025). Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF. Journal of the American College of Cardiology. 86(4). 242–255. 5 indexed citations
4.
Packer, Milton, et al.. (2025). Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity. Journal of the American College of Cardiology. 85(18). 1721–1735. 8 indexed citations
5.
Tian, Yu, Siyi Zou, Yang Ou, et al.. (2025). Glass fiber-interfaced CRISPR/Cas biosensing adaptable for diverse biomarker detection. Trends in biotechnology. 43(8). 2003–2028. 2 indexed citations
6.
Borlaug, Barry A., Michael R. Zile, Christopher M. Kramer, et al.. (2025). HFpEF-ABA score is a more useful enrichment tool than natriuretic peptides in heart failure with preserved ejection fraction. European Heart Journal. 46(43). 4607–4609. 1 indexed citations
7.
Packer, Milton, Michael R. Zile, Christopher M. Kramer, et al.. (2025). Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity. Journal of the American College of Cardiology. 86(10). 696–707. 1 indexed citations
8.
Kramer, Christopher M., Barry A. Borlaug, Dustin Ruff, et al.. (2024). Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure. Journal of the American College of Cardiology. 85(7). 699–706. 63 indexed citations breakdown →
9.
Li, Yuxin, et al.. (2024). Salivary diagnostics: opportunities and challenges. Theranostics. 14(18). 6969–6990. 15 indexed citations
10.
Zile, Michael R., Barry A. Borlaug, Christopher M. Kramer, et al.. (2024). Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity. Circulation. 151(10). 656–668. 22 indexed citations
11.
Ou, Yang, Yang Yan, Xuefeng Li, et al.. (2023). Arginine metabolism key enzymes affect the prognosis of myelodysplastic syndrome by interfering with macrophage polarization. Cancer Medicine. 12(15). 16444–16454. 3 indexed citations
12.
Ou, Yang, et al.. (2020). Hypertension Accompanied by Hyperaldosteronism, Hyperkalemia, and Hyperchloremic Acidosis: A Case Report and Literature Review. Case Reports in Endocrinology. 2020(1). 1635413–1635413. 3 indexed citations
13.
Huang, Longbin, et al.. (2020). Association between MAFB rs17820943 and rs6072081 polymorphism and risk of nonsyndromic cleft lip with or without cleft palate: a meta-analysis. British Journal of Oral and Maxillofacial Surgery. 58(9). 1065–1072. 3 indexed citations
14.
15.
16.
17.
Ou, Yang, et al.. (2019). High throughput, efficacious gene editing & genome surveillance in Chinese hamster ovary cells. PLoS ONE. 14(12). e0218653–e0218653. 9 indexed citations
18.
Li, Qing, Jingcao Huang, Yang Ou, Li Yan, & Yu Wu. (2019). Progressive Diffuse Large B-cell Lymphoma with TP53 Gene Mutation Treated with Chidamide-Based Chemotherapy. Immunotherapy. 11(4). 265–272. 16 indexed citations
19.
Ou, Yang, Junwei Huang, & Liping Yang. (2018). The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review. Bioscience Reports. 38(6). 15 indexed citations
20.
Ou, Yang, M. Dror Michaelson, L. Sengeløv, et al.. (2011). Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 29(15_suppl). 4515–4515. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kira Kuschnerus Breakdown of academic impact, for papers by Yasuhiko Nakao Breakdown of academic impact, for papers by Cristina Fhied Breakdown of academic impact, for papers by L van Toorn Breakdown of academic impact, for papers by Fong To Breakdown of academic impact, for papers by Maiko Hajime Breakdown of academic impact, for papers by Joshua Balog Breakdown of academic impact, for papers by Emina Vorkapić Breakdown of academic impact, for papers by Chun Huang
Rankless by CCL
2026